戻る
Sanofi Stock Performance Reflects Strategic Realignment and Strong Dupixent Growth
戻る
株式ニュース
テーマ
Sanofi Stock Performance Reflects Strategic Realignment and Strong Dupixent Growth
Sanofi Stock Performance Reflects Strategic Realignment and Strong Dupixent Growth
Edgen Stock
·
Oct 05 2025, 09:27
共有先
共有先
リンクをコピー
ソース：
[1] Sanofi: Undervalued 2026 Pipeline, And Solid Results (Rating Upgrade) (NASDAQ:SNY) | Seeking Alpha
[2] Sanofi's investment strategy for transitioning to a pure biopharma - Labiotech.eu
[3] Regeneron Reports Second Quarter 2025 Financial and Operating Results
Edgen Stock·Oct 05 2025, 09:27Edgen Stock·Oct 05 2025, 09:27
Edgen Stock·Oct 05 2025, 09:27